Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

992 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Somatostatin receptor expression in thymic tumors.
Ferone D, Montella L, De Chiara A, Hofland LJ, Lamberts SW, Palmieri G. Ferone D, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14:3304-9. doi: 10.2741/3453. Front Biosci (Landmark Ed). 2009. PMID: 19273275
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study.
Lattanzio R, La Sorda R, Facciolo F, Sioletic S, Lauriola L, Martucci R, Gallo E, Palmieri G, Evoli A, Alessandrini G, Ruco L, Rendina EA, Truini M, Chiarle R, Barreca A, Pich A, Ascani S, Remotti D, Tunesi G, Granone P, Ratto GB, Puma F, Pescarmona E, Piantelli M, Marino M; Thymic Epithelial Tumor Working Group, Carlini S, Cerasoli V, Corzani F, Melis E, Filippetti M, Canalini P, Palestro G, Lalle M, Ruffini E, Ceribelli A, Rinaldi M. Lattanzio R, et al. Lung Cancer. 2014 Aug;85(2):191-6. doi: 10.1016/j.lungcan.2014.05.010. Epub 2014 May 22. Lung Cancer. 2014. PMID: 24908332 Clinical Trial.
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor.
Moretto R, Cella CA, Raimondo L, Formisano L, Nappi L, Rescigno P, Buonerba C, Calabrese F, Ottaviano M, Di Lorenzo G, Matano E, Damiano V, Palmieri G. Moretto R, et al. Anticancer Drugs. 2013 Aug;24(7):759-64. doi: 10.1097/CAD.0b013e328362a68b. Anticancer Drugs. 2013. PMID: 23695010
Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S. De Luca S, et al. Clin Nucl Med. 2013 May;38(5):354-8. doi: 10.1097/RLU.0b013e318286bd84. Clin Nucl Med. 2013. PMID: 23486323
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies.
Palmieri G, Buonerba C, Federico P, Formisano L, Nappi L, Di Lorenzo G, Marino M, Damiano V. Palmieri G, et al. World J Clin Oncol. 2012 Jul 10;3(7):111-5. doi: 10.5306/wjco.v3.i7.111. World J Clin Oncol. 2012. PMID: 22787579 Free PMC article.
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors.
Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S. Segreto S, et al. Cancer Imaging. 2017 Mar 7;17(1):10. doi: 10.1186/s40644-017-0112-x. Cancer Imaging. 2017. PMID: 28264726 Free PMC article.
Imatinib mesylate in thymic epithelial malignancies.
Palmieri G, Marino M, Buonerba C, Federico P, Conti S, Milella M, Petillo L, Evoli A, Lalle M, Ceribelli A, Merola G, Matano E, Sioletic S, De Placido S, Di Lorenzo G, Damiano V. Palmieri G, et al. Cancer Chemother Pharmacol. 2012 Feb;69(2):309-15. doi: 10.1007/s00280-011-1690-0. Epub 2011 Jun 28. Cancer Chemother Pharmacol. 2012. PMID: 21710245 Clinical Trial.
Cetuximab is an active treatment of metastatic and chemorefractory thymoma.
Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L. Palmieri G, et al. Front Biosci. 2007 Jan 1;12:757-61. doi: 10.2741/2098. Front Biosci. 2007. PMID: 17127335
Somatostatin analogs and prednisone in advanced refractory thymic tumors.
Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, Lastoria S. Palmieri G, et al. Cancer. 2002 Mar 1;94(5):1414-20. doi: 10.1002/cncr.10374. Cancer. 2002. PMID: 11920496 Clinical Trial.
992 results
Jump to page
Feedback